SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 9 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is 0.99 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,792 | +10.2% | 131 | 0.0% | 0.02% | +8.7% |
Q2 2023 | $25,212 | -4.9% | 131 | 0.0% | 0.02% | -4.2% |
Q1 2023 | $26,524 | +155923.5% | 131 | 0.0% | 0.02% | +50.0% |
Q4 2022 | $17 | -99.9% | 131 | 0.0% | 0.02% | -5.9% |
Q3 2022 | $18,000 | -21.7% | 131 | 0.0% | 0.02% | -15.0% |
Q2 2022 | $23,000 | +21.1% | 131 | 0.0% | 0.02% | +42.9% |
Q1 2022 | $19,000 | – | 131 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |